Skip to content

Pterygomaxillary Disjunction With Interpositional Y-shape Plate in Patients With Temporomandibular Joint Derangement

Evaluation of Pterygomaxillary Disjunction With Interpositional Y-shape Plate as an Innovative Minimally Invasive Technique in Patients With Temporomandibular Joint Internal Derangement (Clinical Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05561465
Enrollment
12
Registered
2022-09-30
Start date
2021-11-01
Completion date
2022-06-30
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorder

Brief summary

Temporomandibular joint internal derangement (TMJ ID) is the most frequent type of temporomandibular disorder (TMDs)which is managed by different therapeutic modalities. it begins with conservative methods like medical treatment, physiotherapy, thermotherapy, and bites appliance therapy. Surgical intervention is a controversial issue in cases not responding to conservative methods. A novel minimally invasive surgical technique which is extracapsular trans oral (Pterygomaxillary disjunction) has been advocated as a minimally invasive extracapsular technique that preserves TMJ integrity.

Interventions

PROCEDUREPterygomaxillary disjunction with interposition Y-shape plate

All patients will be treated under general anesthesia. The pterygoid plate will be fractured, pried up, and pushed backward. A Y-shape plate will be fixed to the lateral maxillary surface with its vertical limb and the other two limbs are turned to fit into the retro maxillary space preventing the reattachment of the fractured pterygoid plate

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients without relevant disease * Patients refractory to conservative treatment \> 6 months. * Patients are diagnosed, with unilateral/bilateral anterior disc displacement without reduction, clinically and by MRI recently. * No previous TMJ surgery. * No previous maxillofacial trauma.

Exclusion criteria

* Patients with systemic joint disease (rheumatoid, osteoarthritis, gouts). * Medically compromised patients contraindicating operation. * Patients to whom general anesthesia is contraindicated. * Patient with neuromuscular disorders. * Patients with any gross pathology of the ear. * Patient with psychoneurotic disorders.

Design outcomes

Primary

MeasureTime frameDescription
Change in wound healing1st week and 2nd weekThe sutured wounds will be examined after one and two weeks for signs and symptoms of infection including swelling, redness, hotness, pus discharge, and pain in addition to observation for any manifestations of wound healing disturbance, as wound dehiscence and hardware exposure.
Change in TMJ clinical dysfunction1st week, 2nd week, 1 month, and 3 monthsHelkimo's dysfunction index is used, including the interincisal opening of the mandible, deviation during the opening, dysfunction of TMJ, pain in the TMJ and preauricular region, and also masticatory muscles were palpated for pain during the follow-up periods.
disc positionat 3 monthsMRI assessment by proton-density (PD), Evaluation by MRI will be done after 3 months to assure disc position.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026